Thermo Fisher Scientific (TMO)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$8.50 (+1.63%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).

Key Insights

Critical company metrics and information

  • Share Price

    $529.36

  • Market Cap

    $202.48 Billion

  • Total Outstanding Shares

    382.50 Million Shares

  • Total Employees

    122,000

  • Dividend

    $0.39 Per Share Quarterly

  • IPO Date

    August 27, 1980

  • SIC Description

    Measuring & Controlling Devices, Nec

  • Homepage

    https://www.thermofisher.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

September 29, 2023 to September 28, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$9.10 Billion
Net Cash Flow From Operating Activities$9.10 Billion
Net Cash Flow From Financing Activities$-4.55 Billion
Net Cash Flow From Financing Activities, Continuing$-4.55 Billion
Net Cash Flow From Investing Activities$-6.24 Billion
Net Cash Flow$-1.69 Billion
Net Cash Flow From Investing Activities, Continuing$-6.24 Billion
Net Cash Flow, Continuing$-1.69 Billion

Income Statement

September 29, 2023 to September 28, 2024
MetricValue
Basic Average Shares$382.00 Million
Income/Loss From Continuing Operations After Tax$6.20 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Other Operating Expenses$25.33 Billion
Income/Loss Before Equity Method Investments$6.84 Billion
Selling, General, and Administrative Expenses$8.52 Billion
Diluted Average Shares$383.00 Million
Net Income/Loss Attributable To Parent$6.13 Billion
Benefits Costs and Expenses$35.53 Billion
Costs And Expenses$35.20 Billion
Operating Expenses$35.20 Billion
Diluted Earnings Per Share$15.95
Net Income/Loss$6.12 Billion
Income Tax Expense/Benefit$640.00 Million
Net Income/Loss Attributable To Noncontrolling Interest$-15.00 Million
Income/Loss From Continuing Operations Before Tax$6.84 Billion
Research and Development$1.34 Billion
Revenues$42.37 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Attributable To Redeemable Noncontrolling Interest$17.00 Million
Net Income/Loss Available To Common Stockholders, Basic$6.13 Billion
Operating Income/Loss$7.17 Billion
Basic Earnings Per Share$16.00
Income/Loss From Equity Method Investments$-76.00 Million

Balance Sheet

September 29, 2023 to September 28, 2024
MetricValue
Equity Attributable To Parent$48.99 Billion
Assets$100.36 Billion
Current Liabilities$14.60 Billion
Long-term Debt$35.11 Billion
Liabilities And Equity$100.36 Billion
Equity$48.97 Billion
Noncurrent Liabilities$36.79 Billion
Noncurrent Assets$76.58 Billion
Other Current Liabilities$10.17 Billion
Temporary Equity$127.00 Million
Redeemable Noncontrolling Interest$127.00 Million
Other Current Assets$18.35 Billion
Fixed Assets$9.41 Billion
Liabilities$51.39 Billion
Intangible Assets$16.26 Billion
Wages$1.82 Billion
Equity Attributable To Noncontrolling Interest$-20.00 Million
Current Assets$23.78 Billion
Other Non-current Assets$50.91 Billion
Other Non-current Liabilities$1.68 Billion
Accounts Payable$2.61 Billion
Inventory$5.43 Billion

Historical Dividends

Current dividend: $0.39 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Nov 7, 2024Jan 15, 2025Dec 13, 2024$0.39Quarterly
Jul 11, 2024Oct 15, 2024Sep 13, 2024$0.39Quarterly
May 22, 2024Jul 15, 2024Jun 14, 2024$0.39Quarterly
Feb 21, 2024Apr 15, 2024Mar 15, 2024$0.39Quarterly
Nov 9, 2023Jan 16, 2024Dec 15, 2023$0.35Quarterly
Jul 13, 2023Oct 13, 2023Sep 15, 2023$0.35Quarterly
May 24, 2023Jul 14, 2023Jun 15, 2023$0.35Quarterly
Feb 22, 2023Apr 14, 2023Mar 15, 2023$0.35Quarterly
Nov 10, 2022Jan 16, 2023Dec 15, 2022$0.3Quarterly
Jul 7, 2022Oct 14, 2022Sep 15, 2022$0.3Quarterly
May 18, 2022Jul 15, 2022Jun 15, 2022$0.3Quarterly
Feb 23, 2022Apr 14, 2022Mar 16, 2022$0.3Quarterly
Nov 4, 2021Jan 14, 2022Dec 15, 2021$0.26Quarterly
Jul 8, 2021Oct 15, 2021Sep 15, 2021$0.26Quarterly
May 19, 2021Jul 15, 2021Jun 15, 2021$0.26Quarterly
Feb 23, 2021Apr 16, 2021Mar 16, 2021$0.26Quarterly
Nov 5, 2020Jan 15, 2021Dec 15, 2020$0.22Quarterly
Jul 9, 2020Oct 15, 2020Sep 15, 2020$0.22Quarterly
May 20, 2020Jul 15, 2020Jun 15, 2020$0.22Quarterly
Feb 25, 2020Apr 16, 2020Mar 16, 2020$0.22Quarterly
Nov 8, 2019Jan 15, 2020Dec 17, 2019$0.19Quarterly
Jul 11, 2019Oct 15, 2019Sep 17, 2019$0.19Quarterly
May 23, 2019Jul 16, 2019Jun 14, 2019$0.19Quarterly
Feb 26, 2019Apr 16, 2019Mar 15, 2019$0.19Quarterly
Nov 8, 2018Jan 15, 2019Dec 17, 2018$0.17Quarterly
Jul 13, 2018Oct 15, 2018Sep 17, 2018$0.17Quarterly
May 24, 2018Jul 16, 2018Jun 15, 2018$0.17Quarterly
Jan 31, 2018Apr 16, 2018Mar 15, 2018$0.17Quarterly
Nov 9, 2017Jan 15, 2018Dec 15, 2017$0.15Quarterly
Jul 12, 2017Oct 16, 2017Sep 15, 2017$0.15Quarterly
May 18, 2017Jul 17, 2017Jun 15, 2017$0.15Quarterly
Feb 28, 2017Apr 17, 2017Mar 15, 2017$0.15Quarterly
Jul 7, 2016Oct 17, 2016Sep 15, 2016$0.15Quarterly
May 18, 2016Jul 15, 2016Jun 15, 2016$0.15Quarterly
Feb 25, 2016Apr 15, 2016Mar 15, 2016$0.15Quarterly
Nov 12, 2015Jan 15, 2016Dec 15, 2015$0.15Quarterly
Jul 10, 2015Oct 15, 2015Sep 15, 2015$0.15Quarterly
May 21, 2015Jul 15, 2015Jun 15, 2015$0.15Quarterly
Feb 25, 2015Apr 15, 2015Mar 16, 2015$0.15Quarterly
Nov 6, 2014Jan 15, 2015Dec 15, 2014$0.15Quarterly
Jul 10, 2014Oct 15, 2014Sep 15, 2014$0.15Quarterly
May 20, 2014Jul 15, 2014Jun 16, 2014$0.15Quarterly
Feb 26, 2014Apr 15, 2014Mar 17, 2014$0.15Quarterly
Nov 7, 2013Jan 15, 2014Dec 16, 2013$0.15Quarterly
Jul 11, 2013Oct 15, 2013Sep 16, 2013$0.15Quarterly
May 22, 2013Jul 15, 2013Jun 17, 2013$0.15Quarterly
Feb 26, 2013Apr 15, 2013Mar 15, 2013$0.15Quarterly
Nov 8, 2012Jan 15, 2013Dec 17, 2012$0.15Quarterly

Related Companies

View additional S&P 500 companies similar to Thermo Fisher Scientific (TMO)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.